KTTA
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 22, 2026.
- Industry:Biotechnology
- CEO:Tiago Reis Marques
- Employees:4
- HQ:Miami Beach, FL, US
- IPO:2021-09-15
Insider Buying
$53K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$16.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Coastlands Capital LPFirst filing | 10% Owner | Purchase | 100,000 | $53K | Jun 22 | SEC ↗ |
Related companies
Pasithea Therapeutics Corp. is in the Healthcare sector.